{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:54:26Z","timestamp":1773086066479,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1002\/jps.20489","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T23:18:16Z","timestamp":1130541496000},"page":"2632-2643","source":"Crossref","is-referenced-by-count":26,"title":["pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: Kinetic analysis of quinidine efflux in situ"],"prefix":"10.1016","volume":"94","author":[{"given":"Manthena V.S.","family":"Varma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Panchagnula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20489_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20489_bb0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1002\/jps.20489_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1043-6618(03)00158-0","article-title":"P-glycoprotein inhibitors and their screening: A perspective from bioavailability enhancement","volume":"48","author":"Varma","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1002\/jps.20489_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1018872207437","article-title":"Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption\u2014theoretical approach","volume":"16","author":"Ito","year":"1999","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20489_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp0499196","article-title":"Functional role of P-glycoprotein in limiting intestinal absorption of drugs: Contribution of passive permeability to P-glycoprotein-mediated efflux transport","volume":"2","author":"Varma","year":"2005","journal-title":"Mol Pharm"},{"key":"10.1002\/jps.20489_bb0035","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/jps.20309","article-title":"Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability","volume":"94","author":"Varma","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20489_bb0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1568026013395100","article-title":"Physicochemical profiling (solubility, permeability, and charge state)","volume":"1","author":"Avdeef","year":"2001","journal-title":"Curr Topic Med Chem"},{"key":"10.1002\/jps.20489_bb0045","first-page":"116","article-title":"Absorption and drug development","author":"Avdeef","year":"2003"},{"key":"10.1002\/jps.20489_bb0050","first-page":"275","article-title":"On the mechanism of intestinal absorption of drugs","volume":"125","author":"Hogben","year":"1959","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20489_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1011954332221","article-title":"pH-metric logP 10. Determination of liposomal membrane\u2212water partition coefficients of ionizable drugs","volume":"15","author":"Avdeef","year":"1998","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20489_bb0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3565(24)35123-7","article-title":"Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs","volume":"291","author":"Palm","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20489_bb0065","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1023\/A:1016065715308","article-title":"Comparison between permeability coefficients in rat and human jejunum","volume":"13","author":"Fagerholm","year":"1996","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20489_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(96)00424-3","article-title":"Discrimination between drug candidates using models for evaluation of intestinal absorption","volume":"23","author":"Stewart","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20489_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-409X(02)00170-9","article-title":"In vitro and in vivo models for assessing drug efflux transporter activity","volume":"55","author":"Zhang","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20489_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1011076217118","article-title":"A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells","volume":"18","author":"Gao","year":"2001","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20489_bb0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs","volume":"303","author":"Mahar Doan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20489_bb0090","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/js980378j","article-title":"Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein","volume":"88","author":"Doppenschmitt","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20489_bb0095","first-page":"3531","article-title":"Assessment of drug-induced dysregulations among seven resistance-associated genes in human tumour cell lines","volume":"16","author":"Van Hille","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1002\/jps.20489_bb0100","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J Med Chem"},{"key":"10.1002\/jps.20489_bb0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejps.2003.10.009","article-title":"PAMPA\u2014a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones","volume":"21","author":"Bermejo","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20489_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bmc.2003.10.002","article-title":"Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: Application to prediction of Caco-2 cell permeability","volume":"12","author":"Ano","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1002\/jps.20489_bb0115","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.2042-7158.1997.tb06093.x","article-title":"Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms","volume":"49","author":"Fagerholm","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20489_bb0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0928-0987(00)00195-0","article-title":"Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats","volume":"12","author":"Hanafy","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20489_bb0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jchromb.2004.11.040","article-title":"pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs. 1. Simultaneous determination of quinidine and permeability markers in rat in situ perfusion samples","volume":"816","author":"Varma","year":"2005","journal-title":"J Chromatogr B"},{"key":"10.1002\/jps.20489_bb0130","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1023\/A:1023481418576","article-title":"Human jejunal permeability of cyclosporin A: Influence of surfactants on P-glycoprotein efflux in Caco-2 cells","volume":"20","author":"Chiu","year":"2003","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20489_bb0135","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1025001131513","article-title":"Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium","volume":"20","author":"Troutman","year":"2003","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20489_bb0140","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-3565(24)29498-2","article-title":"Kinetics of P-glycoprotein-mediated efflux of paclitaxel","volume":"298","author":"Jang","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20489_bb0145","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1124\/jpet.102.041236","article-title":"Region-dependent modulation of intestinal permeability by drug efflux transporters: In vitro studies in mdr1a(\u2212\/\u2212) mouse intestine","volume":"303","author":"Stephens","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20489_bb0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1389200043489144","article-title":"Intestinal drug transporters: In vivo function and clinical importance","volume":"5","author":"Kunta","year":"2004","journal-title":"Curr Drug Metab"},{"key":"10.1002\/jps.20489_bb0155","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1023\/A:1025032511040","article-title":"pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: Implications for drug\u2212drug interactions","volume":"20","author":"Neuhoff","year":"2003","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20489_bb0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/js970294v","article-title":"Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine","volume":"87","author":"Emi","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20489_bb0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/1389200043335423","article-title":"Biopharmaceutic classification system: A scientific framework for pharmacokinetic optimization in drug research","volume":"5","author":"Varma","year":"2004","journal-title":"Curr Drug Metab"},{"key":"10.1002\/jps.20489_bb0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0005-2736(89)90211-3","article-title":"Lipid permeability of the intestinal microvillus membrane may be modulated by membrane fluidity in the rat","volume":"984","author":"Meddings","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.20489_bb0175","doi-asserted-by":"crossref","first-page":"9735","DOI":"10.1073\/pnas.90.20.9735","article-title":"Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance","volume":"90","author":"Altenberg","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.20489_bb0180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1023\/A:1016140429238","article-title":"Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?","volume":"19","author":"Tang","year":"2002","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20489_bb0185","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-3565(24)38782-8","article-title":"Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia","volume":"296","author":"Stephens","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20489_bb0190","series-title":"Handbook of physiology","first-page":"371","article-title":"Transport of weak electrolytes","author":"Rechkemmer","year":"1991"},{"key":"10.1002\/jps.20489_bb0195","series-title":"Handbook of physiology","first-page":"83","article-title":"Functional morphology of epithelium of the small intestine","author":"Madara","year":"1991"},{"key":"10.1002\/jps.20489_bb0200","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/jps.2600671219","article-title":"GI absorption of beta-lactam antibiotics II: Deviation from pH-partition hypothesis in penicillin absorption through in situ and in vitro lipoidal barriers","volume":"67","author":"Tsuji","year":"1978","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916318986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916318986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T07:21:58Z","timestamp":1736061718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916318986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0022354916318986"],"URL":"https:\/\/doi.org\/10.1002\/jps.20489","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}